Attached files

file filename
8-K - FORM 8-K - WebMD Health Corp.g27807e8vk.htm
EX-99.4 - EX-99.4 - WebMD Health Corp.g27807exv99w4.htm
EX-99.1 - EX-99.1 - WebMD Health Corp.g27807exv99w1.htm
EX-99.3 - EX-99.3 - WebMD Health Corp.g27807exv99w3.htm
Exhibit 99.2
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2011     2010     2011     2010  
Revenue
  $ 141,369     $ 122,707     $ 272,978     $ 230,737  
Cost of operations
    51,152       45,368       99,601       88,362  
Sales and marketing
    32,270       29,425       64,564       57,832  
General and administrative
    22,006       20,577       44,827       39,386  
Depreciation and amortization
    6,724       6,318       13,148       13,333  
Interest income
    51       420       67       3,829  
Interest expense
    5,833       3,170       8,974       8,309  
Loss on convertible notes
          11,011             14,738  
Gain (loss) on investments
    1,769       6,002       15,829       (22,846 )
Other income (expense), net
          99       (53 )     (199 )
 
                       
Income (loss) from continuing operations before income tax provision (benefit)
    25,204       13,359       57,707       (10,439 )
Income tax provision (benefit)
    11,003       5,675       23,961       (14,333 )
 
                       
Income from continuing operations
    14,201       7,684       33,746       3,894  
Income from discontinued operations, net of tax
    7,394             7,394        
 
                       
Net income
  $ 21,595     $ 7,684     $ 41,140     $ 3,894  
 
                       
 
Basic income per common share:
                               
Income from continuing operations
  $ 0.24     $ 0.14     $ 0.58     $ 0.07  
Income from discontinued operations
    0.13             0.12        
 
                       
Net income
  $ 0.37     $ 0.14     $ 0.70     $ 0.07  
 
                       
 
Diluted income per common share:
                               
Income from continuing operations
  $ 0.23     $ 0.13     $ 0.55     $ 0.07  
Income from discontinued operations
    0.13             0.13        
 
                       
Net income
  $ 0.36     $ 0.13     $ 0.68     $ 0.07  
 
                       
 
Weighted-average shares outstanding used in computing income per common share:
                               
Basic
    58,096       53,521       58,140       52,856  
 
                       
Diluted
    60,236       62,504       60,473       57,272  
 
                       

 


 

WEBMD HEALTH CORP.
CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION
(In thousands, unaudited)
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2011     2010     2011     2010  
Revenue
                               
Public portal advertising and sponsorship
  $ 121,108     $ 100,592     $ 231,471     $ 186,849  
Private portal services
    20,261       22,115       41,507       43,888  
 
                       
 
  $ 141,369     $ 122,707     $ 272,978     $ 230,737  
 
                       
Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”) (a)
  $ 45,289     $ 34,301     $ 83,147     $ 59,958  
 
Interest, taxes, non-cash and other items (b)
                               
Interest income
    51       420       67       3,829  
Interest expense
    (5,833 )     (3,170 )     (8,974 )     (8,309 )
Income tax (provision) benefit
    (11,003 )     (5,675 )     (23,961 )     14,333  
Depreciation and amortization
    (6,724 )     (6,318 )     (13,148 )     (13,333 )
Non-cash stock-based compensation
    (9,348 )     (6,964 )     (19,161 )     (14,801 )
Loss on convertible notes
          (11,011 )           (14,738 )
Gain (loss) on investments
    1,769       6,002       15,829       (22,846 )
Other income (expense), net
          99       (53 )     (199 )
 
                       
Income from continuing operations
    14,201       7,684       33,746       3,894  
Income from discontinued operations, net of tax
    7,394             7,394        
 
                       
Net income
  $ 21,595     $ 7,684     $ 41,140     $ 3,894  
 
                       
 
(a)   See Annex A-Explanation of Non-GAAP Financial Measures.
 
(b)   Reconciliation of Adjusted EBITDA to net income.

 


 

WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
                 
    June 30, 2011     December 31, 2010  
Assets
               
Cash and cash equivalents
  $ 1,145,061     $ 400,501  
Accounts receivable, net
    115,214       134,448  
Prepaid expenses and other current assets
    17,913       12,161  
Deferred tax assets
    21,527       23,467  
 
           
Total current assets
    1,299,715       570,577  
 
Property and equipment, net
    58,290       61,516  
Goodwill
    202,104       202,104  
Intangible assets, net
    21,313       22,626  
Deferred tax assets
    63,827       71,125  
Other assets
    33,420       14,254  
 
           
Total Assets
  $ 1,678,669     $ 942,202  
 
           
 
Liabilities and Stockholders’ Equity
               
Accrued expenses
  $ 56,701     $ 53,181  
Deferred revenue
    95,999       97,043  
Liabilities of discontinued operations
    4,804       17,327  
 
           
Total current liabilities
    157,504       167,551  
 
2.25% convertible notes due 2016
    400,000        
2.50% convertible notes due 2018
    400,000        
Other long-term liabilities
    22,401       21,756  
 
Stockholders’ equity
    698,764       752,895  
 
 
           
Total Liabilities and Stockholders’ Equity
  $ 1,678,669     $ 942,202  
 
           

 


 

WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
                 
    Six Months Ended  
    June 30,  
    2011     2010  
Cash flows from operating activities:
               
Net income
  $ 41,140     $ 3,894  
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
               
Income from discontinued operations, net of tax
    (7,394 )      
Depreciation and amortization
    13,148       13,333  
Non-cash interest, net
    1,599       3,885  
Non-cash stock-based compensation
    19,161       14,801  
Deferred income taxes
    4,423       (27,729 )
Loss on convertible notes
          14,738  
(Gain) loss on investments
    (15,829 )     22,846  
Changes in operating assets and liabilities:
               
Accounts receivable
    19,234       13,248  
Prepaid expenses and other, net
    (2,103 )     (2,144 )
Accrued expenses and other long-term liabilities
    4,765       (4,801 )
Deferred revenue
    (1,044 )     14,596  
 
           
Net cash provided by continuing operations
    77,100       66,667  
Net cash used in discontinued operations
    (136 )     (15,501 )
 
           
Net cash provided by operating activities
    76,964       51,166  
 
               
Cash flows from investing activities:
               
Proceeds from sales of available-for-sale securities
          361,852  
Proceeds received from ARS option
    16,561       354  
Purchases of property and equipment
    (9,557 )     (9,719 )
Finalization of sale price of discontinued operations
          (1,430 )
 
           
Net cash provided by investing activities
    7,004       351,057  
 
               
Cash flows from financing activities:
               
Proceeds from exercise of stock options
    25,053       48,114  
Cash used for withholding taxes due on stock-based awards
    (6,632 )     (39,728 )
Net proceeds from issuance of the 2.50% Notes and 2.25% Notes
    774,745        
Repurchases of 1.75% Notes and 3 1/8% Notes
          (81,362 )
Purchases of treasury stock
    (150,417 )     (264,527 )
Excess tax benefit on stock-based awards
    17,843       10,219  
 
           
Net cash provided by (used in) financing activities
    660,592       (327,284 )
 
           
Net increase in cash and cash equivalents
    744,560       74,939  
Cash and cash equivalents at beginning of period
    400,501       459,766  
 
           
Cash and cash equivalents at end of period
  $ 1,145,061     $ 534,705  
 
           

 


 

WEBMD HEALTH CORP.
NET INCOME PER COMMON SHARE
(In thousands, except per share data, unaudited)
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2011     2010     2011     2010  
Numerator:
                               
Income from continuing operations
  $ 14,201     $ 7,684     $ 33,746     $ 3,894  
Effect of participating non-vested restricted stock
    (91 )     (88 )     (255 )     (50 )
 
                       
Income from continuing operations- Basic
    14,110       7,596       33,491       3,844  
Interest expense on 1.75% Notes, net of tax
          592              
 
                       
Income from continuing operations- Diluted
  $ 14,110     $ 8,188     $ 33,491     $ 3,844  
 
                       
 
                               
Income from discontinued operations, net of tax
  $ 7,394     $     $ 7,394     $  
Effect of participating non-vested restricted stock
    (47 )           (56 )      
 
                       
Income from discontinued operations, net of tax — Basic and Diluted
  $ 7,347     $     $ 7,338     $  
 
                       
 
                               
Denominator:
                               
Weighted-average shares — Basic
    58,096       53,521       58,140       52,856  
Employee stock options and restricted stock
    2,140       3,848       2,333       4,416  
1.75% Notes
          5,135              
 
                       
Adjusted weighted-average shares after assumed conversions — Diluted
    60,236       62,504       60,473       57,272  
 
                       
 
                               
Basic income per common share:
                               
Income from continuing operations
  $ 0.24     $ 0.14     $ 0.58     $ 0.07  
Income from discontinued operations
    0.13             0.12        
 
                       
Net income
  $ 0.37     $ 0.14     $ 0.70     $ 0.07  
 
                       
 
                               
Diluted income per common share:
                               
Income from continuing operations
  $ 0.23     $ 0.13     $ 0.55     $ 0.07  
Income from discontinued operations
    0.13             0.13        
 
                       
Net income
  $ 0.36     $ 0.13     $ 0.68     $ 0.07